Get started
Author

Radhika Desikan

Observed name: R. Desikan
OpenAlex ID: A5035956940
Development and Validation of the Diabetes Quality of Life Brief Clinical Inventory
2004 · Thomas E. Burroughs, Radhika Desikan, et al. · Diabetes Spectrum · 217
Patient Satisfaction Measurement Strategies: A Comparison of Phone and Mail Methods
2001 · Thomas E. Burroughs, Brian M. Waterman, et al. · The Joint Commission Journal on Quality Improvement · 66
Health-related quality of life and healthcare resource utilization by COPD patients: A comparison of three instruments
2002 · R. Desikan, H.L. Mason, et al. · Quality of Life Research · 33
Reporting of Adverse Drug Events: Examination of a Hospital Incident Reporting System
2005 · Radhika Desikan, Melissa J. Krauss, et al. · 14
Prescribing Authority: An Examination of Ohio Pharmacists' Opinions
1995 · Radhika Desikan, Monica Holiday-Goodman, et al. · American Pharmacy · 6
Survey of Course Curricula of Graduate Programs in Social and Administrative Sciences
1998 · Jamie C. Barner, Radhika Desikan, et al. · American Journal of Pharmaceutical Education · 3
Table 4, Reported rates (per 1,000 patient days) of adverse drug events (ADEs) and alerts by service: RMEES and PHRED
2005 · Radhika Desikan, Melissa J. Krauss, et al.
Table 2, Description of the most frequently reported preventable adverse drug events in RMEES and PHRED
2005 · Radhika Desikan, Melissa J. Krauss, et al.
Table 1, Overall reporting of adverse drug events at Barnes—Jewish Hospital: rates per 1,000 patient days
2005 · Radhika Desikan, Melissa J. Krauss, et al.
Table 3, Event type versus drug class from RMEES and PHRED
2005 · Radhika Desikan, Melissa J. Krauss, et al.
Figure 1, Scatter plot of RMEES potential adverse drug event rates versus preventable adverse drug event rates per 1,000 patient days, by service
2005 · Radhika Desikan, Melissa J. Krauss, et al.
Works count: 11
Citation count: 339
H-index: 5
I10-index: 4
Year
Topic
Type